Lab Members

Elizabeth Owens

Elizabeth has graduated in 2024 from Duke studying Neuroscience, Computer Science, as well as Philosophy, Politics, and Economics. She has trained in single cell RNA analysis at our lab as an honors project during her senior year. She stayed on after graduation to continue as a research technician. She aspires to work in healthcare and […]
Read more

Anna Corcoran

Anna is an undergraduate student studying Statistical Science and Biology. She is training to analyze Xenium spatial transcriptomics data using established and new pipelines that she is developing. She aspires to work in cancer research and plan to enroll in a data science PhD program. In her free time, she enjoys running, hiking, and doing […]
Read more

Eugene Vaios, MD, MBA

NIH K38 Transition Scholar Dr. Vaios started working on this project when he was a radiation oncology resident. He transitioned to a faculty appointment after being awarded an NIH K38 grant that is focused on development of a non-invasive biomarker that could improve diagnosis, risk assessment, and treatment monitoring. His study used cell-free DNA (cfDNA) […]
Read more

Kirit Singh, MD, PhD

Kirit Singh recently earned his PhD in Biomedical Engineering at Duke University and is now continuing in the lab as a postdoctoral associate and Preparing Future Faculty fellow. His research focuses on translational drug development, with a particular emphasis on bi-specific T cell engagers and surgical window-of-opportunity trials.
Read more

Ke-Nan Zhang, MD, PhD

Kenan Zhang is a neurosurgeon from China working on molecular classification and immunotherapeutic research on diffuse glioma. Kenan leads multiple bioinformatics projects and supervises student and technicians. He aspires to become an independent physician-scientist and make a difference for patients with diffuse glioma. He enjoys swimming, cooking food, and PC DIY in his free time.
Read more

Lin Lin, PhD

Lin Lin is an immunologist with expertise in T-cell receptor therapies (TCR-Ts) development. She has a particular interest in identifying TCRs that target glioblastoma-specific antigens and seeks to ultimately develop immunotherapeutic strategies to help effectively treat patients with glioblastoma but also other cancers.
Read more

Kelly Hotchkiss, PhD

Kelly Hotchkiss has expertise in developing pre-clinical immune cell culture, synthetic biology, in vitro and in vivo models as well as evaluations of biological systems from a biomedical engineering perspective.
Read more
Press ESC key to close search